Hasil Pencarian - Moss B

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    P19-52 LB. Assessing and restructuring foreign gene insertion sites for enhanced stability of modified Vaccinia virus ankara recombinants expressing HIV genes

    P19-52 LB. Assessing and restructuring foreign gene insertion sites for enhanced stability of modified Vaccinia virus ankara recombinants expressing HIV genes oleh Moss B, Earl P, Wyatt L

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges

    GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges oleh Robinson H, Kannanganat S, Gangadhara S, Lai L, Yu T, Kozlowski P, Earl P, Moss B, Amara RR

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge

    OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge oleh Moss B, Kozlowski P, Wilson R, Chennareddi L, Lawson B, Earl P, Lai L, Velu V, Nigam P, Kannanganat S, Robinson H, Amara R

    Diterbitkan 2009-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections

    CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections oleh Kwa S, Sadagopal S, Hong J, Gangadhara S, Basu R, Lai L, Iyer S, Araki K, Earl PL, Wyatt L, Villinger F, Moss B, Ahmed R, Amara RR

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting

    P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting oleh Wyatt LS, Moss B, Qin L, Tomaras GD, Sato A, Defawe O, De Rosa S, Xu Y, Lai L, Amara RR, Robinson HL, Hay C, Goepfert P

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA

    P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA oleh Wahren B, Moss B, Earl P, Michael N, Marovich M, Robb M, Brave A, Hejdeman B, Stout R, Mwanyika L, Mbwana J, Janabi M, Lyamuya E, Aris EA, Moshiro C, Buma D, Francis J, Nilsson C, Aboud S, Bakari M, Biberfeld G, Pallangyo K, Mhalu F, Sandstrom E

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: